Veracyte, Inc. (VCYT): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2017-12-31, 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

79.36M
As of 2025-12-31
80.36M
As of 2026-06-30
+3.3%
3-year compound annual growth
+6.4%
5-year compound annual growth
2012-12-31: 667.7K2013-12-31: 21.14M2014-12-31: 22.52M2015-12-31: 27.69M2016-12-31: 33.76M2017-12-31: 33.76M2018-12-31: 40.86M2019-12-31: 49.63M2020-12-31: 58.20M2021-12-31: 71.12M2022-12-31: 71.96M2023-12-31: 73.26M2024-12-31: 77.77M2025-12-31: 79.36M79.36M
2012-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3179.36M+2.0%2026-02-26, Balance as of period end
2024-12-3177.77M+6.2%2026-02-26, Balance as of period end
2023-12-3173.26M+1.8%2025-02-28, Balance as of period end
2022-12-3171.96M+1.2%2024-02-29, Balance as of period end
2021-12-3171.12M+22.2%2023-03-01, Balance as of period end
2020-12-3158.20M+17.3%2022-02-28, Balance as of period end
2019-12-3149.63M+21.4%2021-02-22, Balance as of period end
2018-12-3140.86Mn/c2020-02-25, Balance as of period end
2017-12-3133.76Mn/c2019-02-25, Balance as of period end
2016-12-3133.76M+22.0%2018-02-27, Balance as of period end
2015-12-3127.69M+22.9%2017-03-01, Balance as of period end
2014-12-3122.52M+6.5%2016-03-14, Balance as of period end
2013-12-3121.14Mn/m2015-03-25, Balance as of period end
2012-12-31667.7Kn/a2014-03-20, Balance as of period end